Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4262 |
BisfluoroModafinil
|
Dopamine Receptor | GPCR/G Protein; Neuroscience |
BisfluoroModafinil 是一种莫达非的常见替代品,具有增强认知能力的潜力。其中莫达非尼通常用于研究性嗜睡症。 | |||
T2613 |
Almorexant
阿莫伦特,ACT 078573 |
OX Receptor | GPCR/G Protein; Neuroscience |
Almorexant (ACT 078573) 是一种有效的竞争性食欲素 1 受体 (OX1)/食欲素 2 受体 (OX2) 双重拮抗剂,OX1 和 OX2 的 Ki 值分别为 1.3 和 0.17 nM。 | |||
T6155 |
Almorexant hydrochloride
ACT-078573 hydrochloride,Almorexant HCl |
OX Receptor | GPCR/G Protein; Neuroscience |
Almorexant hydrochloride (ACT-078573 hydrochloride) 是一种有效的竞争性食欲素 1 受体(OX1)/食欲素 2 受体 (OX2) 双重拮抗剂,OX1 和 OX2 的 Ki 值分别为 1.3 和 0.17 nM。 | |||
T60636 |
Pitolisant
Tiprolisant,BF-2.649,BF-2649 |
Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Pitolisant (Tiprolisant) 是一种具有选择性和高效性的非咪唑类重组人组胺 H3 受体拮抗剂,可用于研究发作性睡病患者白天过度嗜睡和猝倒。 | |||
T9770 |
Samelisant
SUVN-G3031 |
Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Samelisant (SUVN-G3031) 是 H3 受体的特异性反向激动剂,对人和大鼠的 Kis 分别为 8.7 nM 和 9.8 nM。 Samelisant 具有抗猝倒作用,可用于关于发作性睡病的研究。 | |||
T39229 |
YNT-185
|
OX Receptor | GPCR/G Protein; Neuroscience |
YNT-185 是一种非肽类、选择性的俄睾丸激素2型受体(OX2R)激动剂,对 OX2 R和 OX1R 的 EC50 值分别为 0.028 μM 和 2.75 μM。此外,YNT-185 在小鼠模型中有效缓解了嗜睡症-猝倒症的症状。 | |||
T19628 |
GSK 189254 HCl
GSK-189254A,GSK 189254A,GSK 189254 hydrochloride,GSK189254A |
Others | Others |
GSK 189254A is a histamine H3 receptor antagonist for the treatment of narcolepsy. Histamine H3 receptor antagonists have been shown to increase the release of neurotransmitters in the brain and to enhance cognition in vivo. The compound may also be usefu | |||
T78636 |
Firazorexton hydrate
TAK-994 |
Others | Others |
Firazorexton hydrate (TAK-994)为一种高效的食欲素2型受体(OX2R)激动剂,EC50值为19 nM。在发作性睡病小鼠模型中,该化合物能够有效减少觉醒碎片和猝倒样发作的发生。 | |||
T37112 |
YNT-185 dihydrochloride
|
Others | Others |
Potent and selective orexin OX2 receptor agonist (EC50 = 28 nM at human OX2 expressed in CHO cells). Displays approximately 100-fold selectivity for OX2 over OX1 (EC50 = 2.75 μM at human OX1 expressed in CHO cells). Depolarizes OX2-expressing histaminergic neurons in mouse brain slices. Increases wake time in wild type mice. Suppresses cataplexy-like symptoms in OX knockout mice. Nagahara et al (2015) Design and synthesis of non-peptide, selective orexin receptor 2 agonists. J.Med.Chem. 58 7931 ... |